Results of US CoreValve High Risk Trial reported at TCT 2014
According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with incremental costs considered acceptable ...
Sep 15, 2014
0
0